|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000019102 |
Summary for VSIG2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000019102 | Gene symbol | VSIG2 |
| Gene name | V-set and immunoglobulin domain containing 2 | |
| HGNC | 17149 | |
| Entrez ID | 23584 | |
| Gene type | protein_coding | |
| Synonyms | VSIG2|CTXL|CTH | |
| UniProtAcc | Q96IQ7 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000019102 | CTH | DB00114 | Pyridoxal phosphate | SmallMoleculeDrug |
| ENSG00000019102 | CTH | DB00151 | Cysteine | SmallMoleculeDrug |
| ENSG00000019102 | CTH | DB02328 | 2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid | SmallMoleculeDrug |
| ENSG00000019102 | CTH | DB03928 | Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol | SmallMoleculeDrug |
| ENSG00000019102 | CTH | DB04217 | L-2-amino-3-butynoic acid | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for VSIG2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| VSIG2 | 3.03e+02 | -1.80e+00 | 6.20e-01 | -2.90e+00 | 3.75e-03 | 2.89e-02 | BRCA |
| VSIG2 | 7.11e+01 | 1.01e+00 | 2.91e-01 | 3.45e+00 | 5.55e-04 | 3.45e-03 | KIRP |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| VSIG2 | 1.87e+02 | -1.07e+00 | 4.16e-01 | -2.58e+00 | 1.00e-02 | 1.97e-02 | LIHC |
| VSIG2 | 2.29e+03 | -3.82e+00 | 8.51e-01 | -4.49e+00 | 7.20e-06 | 1.19e-04 | ESCA |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| VSIG2 | 1.49e+03 | -2.96e+00 | 7.57e-01 | -3.91e+00 | 9.19e-05 | 4.47e-04 | READ |
Top |
Sex-biased somatic mutation for VSIG2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for VSIG2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg10313947 | chr11:124752919 | CGI:chr11:124758471-124759694 | promoter | 4.14e-01 | 2.79e-01 | 2.35e+00 | 1.88e-02 | 2.27e-02 | 1.35e-01 |
| LUSC | cg02082342 | chr11:124752477 | CGI:chr11:124746704-124746930 | promoter | 6.61e-01 | 5.33e-01 | 2.59e+00 | 9.58e-03 | 1.34e-02 | 1.28e-01 |
| LUSC | cg23730696 | chr11:124752548 | CGI:chr11:124746704-124746930 | promoter | 8.20e-01 | 7.17e-01 | 3.00e+00 | 2.70e-03 | 5.18e-03 | 1.03e-01 |
| ESCA | cg23715045 | chr11:124752048 | CGI:chr11:124746704-124746930 | promoter,gene body | 5.47e-01 | 4.02e-01 | 2.16e+00 | 3.05e-02 | 4.39e-02 | 1.45e-01 |
| ESCA | cg24942416 | chr11:124751933 | CGI:chr11:124746704-124746930 | promoter,gene body | 6.10e-01 | 4.50e-01 | 2.50e+00 | 1.24e-02 | 3.71e-02 | 1.60e-01 |
| ESCA | cg02082342 | chr11:124752477 | CGI:chr11:124746704-124746930 | promoter | 6.03e-01 | 3.93e-01 | 2.33e+00 | 1.97e-02 | 4.02e-02 | 2.10e-01 |
| ESCA | cg23730696 | chr11:124752548 | CGI:chr11:124746704-124746930 | promoter | 7.39e-01 | 5.08e-01 | 2.29e+00 | 2.18e-02 | 4.10e-02 | 2.31e-01 |
| CHOL | cg23730696 | chr11:124752548 | CGI:chr11:124746704-124746930 | promoter | 7.52e-01 | 6.47e-01 | 2.51e+00 | 1.22e-02 | 2.39e-02 | 1.06e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg21929875 | chr11:124752200 | CGI:chr11:124746704-124746930 | UTR,promoter,exon,gene body | 4.50e-01 | 5.64e-01 | -2.39e+00 | 1.70e-02 | 2.44e-02 | -1.14e-01 |
| LIHC | cg24942416 | chr11:124751933 | CGI:chr11:124746704-124746930 | promoter,gene body | 6.94e-01 | 5.50e-01 | 2.53e+00 | 1.15e-02 | 1.55e-02 | 1.44e-01 |
| LIHC | cg02082342 | chr11:124752477 | CGI:chr11:124746704-124746930 | promoter | 6.37e-01 | 5.30e-01 | 2.59e+00 | 9.57e-03 | 1.34e-02 | 1.07e-01 |
| LIHC | cg23730696 | chr11:124752548 | CGI:chr11:124746704-124746930 | promoter | 7.97e-01 | 6.85e-01 | 3.71e+00 | 2.04e-04 | 6.61e-04 | 1.12e-01 |
Top |
Exon skipping events with PSI in TCGA for VSIG2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for VSIG2 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for VSIG2 |
TFs related to VSIG2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | PATZ1 | VSIG2 | 4.52e+00 | 9.89e-01 | 3.58e+00 | 5.48e-03 | Male-biased |
| PCPG | FOXM1 | VSIG2 | 4.03e+00 | 9.81e-01 | 3.04e+00 | 4.08e-03 | Male-biased |
| PCPG | STAT2 | VSIG2 | 3.96e+00 | 9.83e-01 | 2.54e+00 | 4.73e-04 | Male-biased |
VSIG2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for VSIG2 |
RBPs related to ES in VSIG2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | HNRNPH2 | exon_skip_78217 | 6.93e+00 | 9.84e-01 | 6.37e+00 | 1.80e-03 | Male-biased |
VSIG2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73040270 | chr11:132231512:T:A | - | 0.200222371176772 | 0.00831169479360854 | KIRP | Female-baised eQTL |
| rs595849 | chr11:125428975:A:G | - | -0.233480159229626 | 0.0137526580702298 | KIRP | Female-baised eQTL |
| rs601720 | chr11:125440352:T:G | - | -0.233480159229626 | 0.0137526580702298 | KIRP | Female-baised eQTL |
| rs614910 | chr11:125441596:T:A | - | -0.233480159229626 | 0.0137526580702298 | KIRP | Female-baised eQTL |
| rs624180 | chr11:125461633:C:A | - | -0.233416222510062 | 0.0139864930986132 | KIRP | Female-baised eQTL |
| rs329661 | chr11:133976291:A:G | - | 0.210421307356807 | 0.0294993699246063 | KIRP | Female-baised eQTL |
| rs493888 | chr11:133962578:C:T | - | 0.209965654580046 | 0.0300408775584885 | KIRP | Female-baised eQTL |
| rs492471 | chr11:118819036:C:T | - | 0.236653337888155 | 0.00829549646169846 | LUSC | Female-baised eQTL |
| rs12419599 | chr11:123697696:G:T | - | 0.117225140916695 | 0.0207934677494745 | STAD | Female-baised eQTL |
| rs4938247 | chr11:116268683:C:G | - | 0.0715427630821772 | 0.0448478114733464 | STAD | Female-baised eQTL |
| rs2845695 | chr11:118044810:A:C | - | 0.195530887648889 | 0.00656173647905177 | BLCA | Female-baised eQTL |
| rs57075453 | chr11:128220270:A:G | - | 0.0524620651768541 | 0.0243849763662177 | LUAD | Female-baised eQTL |
| rs55814025 | chr11:128221954:G:A | - | 0.0524620651768541 | 0.0243849763662177 | LUAD | Female-baised eQTL |
| rs59463611 | chr11:128222062:C:T | - | 0.0524620651768541 | 0.0243849763662177 | LUAD | Female-baised eQTL |
| rs7941313 | chr11:128222306:T:G | - | 0.0524620651768541 | 0.0243849763662177 | LUAD | Female-baised eQTL |
| rs114415453 | chr11:128223995:C:T | - | 0.0489641811107821 | 0.0443807131351214 | LUAD | Female-baised eQTL |
| rs143002123 | chr11:128228937:A:G | - | 0.0489641811107821 | 0.0443807131351214 | LUAD | Female-baised eQTL |
| rs73016905 | chr11:128229448:T:A | - | 0.0489641811107821 | 0.0443807131351214 | LUAD | Female-baised eQTL |
| rs7928271 | chr11:126918754:A:C | - | 0.121221567298958 | 0.00447418483379613 | COAD | Female-baised eQTL |
| rs11221508 | chr11:128906454:C:T | - | 0.115526139826415 | 0.00701359976472872 | COAD | Female-baised eQTL |
| rs11221509 | chr11:128907308:C:T | - | 0.115526139826415 | 0.00701359976472872 | COAD | Female-baised eQTL |
| rs11221511 | chr11:128912667:C:T | - | 0.112004800163969 | 0.00995574478767438 | COAD | Female-baised eQTL |
| rs11221512 | chr11:128915746:G:A | - | 0.110530193075816 | 0.0121143138835679 | COAD | Female-baised eQTL |
| rs78704918 | chr11:128915108:T:G | - | 0.110857621628959 | 0.0183621080245202 | COAD | Female-baised eQTL |
| rs596911 | chr11:120154768:G:A | - | 0.0814535607122289 | 0.0457702373705859 | COAD | Female-baised eQTL |
| rs659912 | chr11:120155533:A:G | - | 0.0814535607122289 | 0.0457702373705859 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1793617 | chr11:131216994:G:A | - | 0.0779516368561142 | 0.00307123397228516 | BLCA | Male-baised eQTL |
| rs1628505 | chr11:131216277:G:A | - | 0.0773292686457185 | 0.00454716941744142 | BLCA | Male-baised eQTL |
| rs1793789 | chr11:131216146:A:G | - | 0.075543160174097 | 0.00550959108402256 | BLCA | Male-baised eQTL |
| rs151167685 | chr11:124948465:C:T | - | 0.123784650469617 | 0.0106291392493431 | BLCA | Male-baised eQTL |
| rs3808996 | chr11:125086402:C:T | - | 0.0875281140914039 | 0.0181422942908175 | BLCA | Male-baised eQTL |
| rs2446882 | chr11:115568580:G:A | - | -0.0621046856926467 | 0.019471944526578 | BLCA | Male-baised eQTL |
| rs1629407 | chr11:131216162:G:A | - | 0.0682410767383002 | 0.0217792277029869 | BLCA | Male-baised eQTL |
| rs2936610 | chr11:126234664:T:G | - | 0.0783066654822146 | 0.0243547641290668 | BLCA | Male-baised eQTL |
| rs2962114 | chr11:126238376:T:G | - | 0.0783066654822146 | 0.0243547641290668 | BLCA | Male-baised eQTL |
| rs682795 | chr11:119112971:C:T | - | -0.0605948109443226 | 0.0291468400319226 | BLCA | Male-baised eQTL |
| rs1113927 | chr11:131227894:G:T | - | 0.0576437350423172 | 0.0311922025529978 | BLCA | Male-baised eQTL |
| rs7107939 | chr11:132536074:G:A | - | 0.0577624268557791 | 0.0334379028564766 | BLCA | Male-baised eQTL |
| rs6421611 | chr11:132531998:T:C | - | 0.0564526861641011 | 0.0376838152571971 | BLCA | Male-baised eQTL |
| rs7119651 | chr11:132537092:A:G | - | 0.0572947482552823 | 0.0379109970579166 | BLCA | Male-baised eQTL |
| rs608444 | chr11:119115920:G:A | - | -0.0581654633006581 | 0.0414834923768245 | BLCA | Male-baised eQTL |
| rs12421095 | chr11:126196683:G:A | - | 0.0754095632763201 | 0.0437332718816883 | BLCA | Male-baised eQTL |
| rs571445 | chr11:119117261:G:A | - | -0.0575728634708123 | 0.0469559191624345 | BLCA | Male-baised eQTL |
| rs4938747 | chr11:119996515:G:A | - | 0.076916196536173 | 0.0476992728342942 | BLCA | Male-baised eQTL |
| rs582240 | chr11:125122939:C:T | - | 0.0682512076203113 | 0.0479576080750482 | BLCA | Male-baised eQTL |
| rs2439470 | chr11:125123148:T:C | - | 0.0682512076203113 | 0.0479576080750482 | BLCA | Male-baised eQTL |
| rs10893487 | chr11:126196334:G:A | - | 0.0744750154349524 | 0.0482366777659572 | BLCA | Male-baised eQTL |
| rs10790793 | chr11:126212318:G:A | - | 0.0713052370823545 | 0.0488592956821232 | BLCA | Male-baised eQTL |
| rs11220405 | chr11:126218929:T:C | - | 0.071198601177462 | 0.0498022284677046 | BLCA | Male-baised eQTL |
| rs76282904 | chr11:115752071:C:T | - | 0.164258115018053 | 0.00057494731284578 | LUAD | Male-baised eQTL |
| rs514527 | chr11:117826005:A:G | - | 0.0807482941482367 | 0.000765459694602537 | LUAD | Male-baised eQTL |
| rs12419464 | chr11:115751630:C:G | - | 0.142053694772273 | 0.00251622729497623 | LUAD | Male-baised eQTL |
| rs8181524 | chr11:115754261:T:A | - | 0.148154292481698 | 0.00266206434558836 | LUAD | Male-baised eQTL |
| rs12797557 | chr11:117383406:G:A | - | 0.0837997429320068 | 0.00460481368317946 | LUAD | Male-baised eQTL |
| rs11223447 | chr11:133358731:A:G | - | 0.0991648735411921 | 0.00549345789307646 | LUAD | Male-baised eQTL |
| rs4600215 | chr11:133359144:C:T | - | 0.0991648735411921 | 0.00549345789307646 | LUAD | Male-baised eQTL |
| rs12288091 | chr11:133359858:C:T | - | 0.0989296732553003 | 0.00577870468693891 | LUAD | Male-baised eQTL |
| rs12277211 | chr11:133355674:A:G | - | 0.0928879770696518 | 0.00819102412016293 | LUAD | Male-baised eQTL |
| rs678776 | chr11:117826029:G:A | - | 0.0662313249114283 | 0.0108771560958252 | LUAD | Male-baised eQTL |
| rs73041452 | chr11:132845926:G:A | - | 0.0874808734280497 | 0.0110932150514894 | LUAD | Male-baised eQTL |
| rs7114524 | chr11:122009793:G:A | - | 0.072975238090924 | 0.016076869667585 | LUAD | Male-baised eQTL |
| rs79207844 | chr11:116934725:G:A | - | 0.119531789225461 | 0.0187228084466432 | LUAD | Male-baised eQTL |
| rs12274590 | chr11:116934980:G:A | - | 0.119531789225461 | 0.0187228084466432 | LUAD | Male-baised eQTL |
| rs12282747 | chr11:133357237:C:A | - | 0.0876238023157013 | 0.018963919443621 | LUAD | Male-baised eQTL |
| rs10894671 | chr11:133355083:C:A | - | 0.0876501348455307 | 0.0190169989552909 | LUAD | Male-baised eQTL |
| rs1944455 | chr11:122015370:C:T | - | 0.0711100859830011 | 0.0224700688805783 | LUAD | Male-baised eQTL |
| rs563828 | chr11:117350454:T:G | - | -0.0660667023646229 | 0.0237726327543153 | LUAD | Male-baised eQTL |
| rs35184536 | chr11:116908097:A:G | - | 0.114333994132225 | 0.0244415704747754 | LUAD | Male-baised eQTL |
| rs1689225 | chr11:130530856:C:T | - | 0.0684582820257577 | 0.0259782917708001 | LUAD | Male-baised eQTL |
| rs78692246 | chr11:116920591:G:A | - | 0.110687093851707 | 0.0312969388499321 | LUAD | Male-baised eQTL |
| rs10892047 | chr11:116922977:C:T | - | 0.110687093851707 | 0.0312969388499321 | LUAD | Male-baised eQTL |
| rs12292371 | chr11:116925232:G:C | - | 0.110687093851707 | 0.0312969388499321 | LUAD | Male-baised eQTL |
| rs12292434 | chr11:116925349:G:A | - | 0.110687093851707 | 0.0312969388499321 | LUAD | Male-baised eQTL |
| rs12285956 | chr11:116926759:G:A | - | 0.110687093851707 | 0.0312969388499321 | LUAD | Male-baised eQTL |
| rs79157715 | chr11:116929554:G:A | - | 0.110687093851707 | 0.0312969388499321 | LUAD | Male-baised eQTL |
| rs75776964 | chr11:116930345:C:G | - | 0.110687093851707 | 0.0312969388499321 | LUAD | Male-baised eQTL |
| rs74615346 | chr11:116932256:A:C | - | 0.110687093851707 | 0.0312969388499321 | LUAD | Male-baised eQTL |
| rs12272491 | chr11:116933654:C:T | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs12418735 | chr11:116934046:T:G | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs11493798 | chr11:116936455:C:A | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs12273769 | chr11:116936457:T:G | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs12294657 | chr11:116936652:G:C | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs77136879 | chr11:116937737:C:T | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs7480278 | chr11:116939073:T:G | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs80015203 | chr11:116940190:A:G | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs117877581 | chr11:116940238:T:G | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs116597701 | chr11:116940771:C:G | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs78066444 | chr11:116941342:A:C | - | 0.110577003269953 | 0.0315903408632263 | LUAD | Male-baised eQTL |
| rs57900379 | chr11:124462399:C:G | - | 0.06737458098607 | 0.0322621363529789 | LUAD | Male-baised eQTL |
| rs11215675 | chr11:115756499:G:A | - | 0.11147186643738 | 0.0331021612279284 | LUAD | Male-baised eQTL |
| rs11216185 | chr11:116912258:T:G | - | 0.110012677690828 | 0.0339563947498112 | LUAD | Male-baised eQTL |
| rs79711490 | chr11:116914625:C:T | - | 0.107246527907158 | 0.0350300855306432 | LUAD | Male-baised eQTL |
| rs12277092 | chr11:116916611:C:T | - | 0.107246527907158 | 0.0350300855306432 | LUAD | Male-baised eQTL |
| rs12418208 | chr11:116916917:C:T | - | 0.107246527907158 | 0.0350300855306432 | LUAD | Male-baised eQTL |
| rs12418209 | chr11:116916925:C:T | - | 0.107246527907158 | 0.0350300855306432 | LUAD | Male-baised eQTL |
| rs1006176 | chr11:116917417:T:C | - | 0.107246527907158 | 0.0350300855306432 | LUAD | Male-baised eQTL |
| rs11218496 | chr11:122021099:T:C | - | 0.0674576279035105 | 0.0355990635303725 | LUAD | Male-baised eQTL |
| rs78694306 | chr11:116903528:G:T | - | 0.107830526220147 | 0.0374092283789993 | LUAD | Male-baised eQTL |
| rs115971514 | chr11:116903783:G:C | - | 0.107830526220147 | 0.0374092283789993 | LUAD | Male-baised eQTL |
| rs17120132 | chr11:116902602:T:A | - | 0.10767796960676 | 0.0381544889615664 | LUAD | Male-baised eQTL |
| rs17120136 | chr11:116903045:T:G | - | 0.10767796960676 | 0.0381544889615664 | LUAD | Male-baised eQTL |
| rs12280030 | chr11:116904480:T:A | - | 0.10767796960676 | 0.0381544889615664 | LUAD | Male-baised eQTL |
| rs12273762 | chr11:116906347:T:A | - | 0.10767796960676 | 0.0381544889615664 | LUAD | Male-baised eQTL |
| rs9651681 | chr11:116907349:T:C | - | 0.10767796960676 | 0.0381544889615664 | LUAD | Male-baised eQTL |
| rs2703765 | chr11:130524958:G:A | - | 0.0630880394391784 | 0.0391270115915686 | LUAD | Male-baised eQTL |
| rs548559 | chr11:131955807:T:A | - | 0.0572298821239607 | 0.0391465241461687 | LUAD | Male-baised eQTL |
| rs17119162 | chr11:116084383:T:G | - | 0.100462789800173 | 0.0413547055570254 | LUAD | Male-baised eQTL |
| rs75255514 | chr11:116118961:C:T | - | 0.0796183169088721 | 0.0447830933555977 | LUAD | Male-baised eQTL |
| rs57983145 | chr11:134613269:A:T | - | 0.102587389924745 | 0.0457176113980883 | LUAD | Male-baised eQTL |
| rs12270974 | chr11:116933289:C:T | - | 0.105728928892096 | 0.0462527995568661 | LUAD | Male-baised eQTL |
| rs1620366 | chr11:130522005:T:C | - | 0.0622691586860238 | 0.0478407591104659 | LUAD | Male-baised eQTL |
| rs11216186 | chr11:116913976:T:C | - | 0.105317899290058 | 0.0486940746033223 | LUAD | Male-baised eQTL |
| rs56098711 | chr11:131094175:T:C | - | 0.103458474220155 | 0.0413312292886416 | COAD | Male-baised eQTL |
| rs60150259 | chr11:131102448:A:G | - | 0.0813949757473769 | 0.0481713705686785 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg24942416 | chr11:124751933 | gene,promoter | -0.495293178747319 | 7.79109113603719e-74 | -0.9107986988749613 | 2.162331350017882e-78 | KIRP |
| cg23715045 | chr11:124752048 | gene,promoter | -0.495293178747319 | 7.79109113603719e-74 | -0.9107986988749613 | 2.162331350017882e-78 | KIRP |
| cg21929875 | chr11:124752200 | gene,exon,promoter,UTR | -0.495293178747319 | 7.79109113603719e-74 | -0.9107986988749613 | 2.162331350017882e-78 | KIRP |
| cg23730696 | chr11:124752548 | promoter | -0.495293178747319 | 7.79109113603719e-74 | -0.9107986988749613 | 2.162331350017882e-78 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of VSIG2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |